WPI 1119 (Mirtazapine 45 mg)

Pill imprint WPI 1119 has been identified as Mirtazapine 45 mg.

Mirtazapine is used in the treatment of major depressive disorder; insomnia; anxiety; depression; hot flashes (and more), and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 45 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WPI 1119

Mirtazapine 45 mg WPI 1119
Mirtazapine
Imprint:
WPI 1119
Strength:
45 mg
Color:
White
Size:
16.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Tetracyclic antidepressants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-1119
Inactive Ingredients:
lactose anhydrous
silicon dioxide
magnesium stearate
microcrystalline cellulose
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
polyethylene glycol 400
polysorbate 80
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
16590-0155 Stat RX USA LLC (repackager)
58016-0282 Southwood Pharmaceuticals Inc (repackager)
63874-1155 Altura Pharmaceuticals Inc (repackager)
68258-7006 Dispensing Solutions Inc. (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)